Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank29
3Y CAGR+29.1%
5Y CAGR+1.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+29.1%/yr
vs -28.2%/yr prior
5Y CAGR
+1.6%/yr
Recent acceleration
Acceleration
+57.2pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $95.14M | -14.6% |
| 2024 | $111.42M | -4.0% |
| 2023 | $116.08M | +162.3% |
| 2022 | $44.27M | -37.1% |
| 2021 | $70.41M | -20.1% |
| 2020 | $88.06M | -28.0% |
| 2019 | $122.24M | -26.6% |
| 2018 | $166.50M | +12.3% |
| 2017 | $148.23M | +6.3% |
| 2016 | $139.49M | - |